Pongas, G N <br/><br/>
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?  [electronic resource] 

 -  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  Oct 2009 
 - 93-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1469-0691 
<br/><br/><label>Standard No.: </label>10.1111/j.1469-0691.2009.02988.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antifungal Agents--adverse effects<br/>Chemoprevention--methods<br/>Drug Resistance, Fungal<br/>Humans<br/>Immunocompromised Host<br/>Mucorales--drug effects<br/>Mucormycosis--etiology<br/>Pyrimidines--adverse effects<br/>Transplantation<br/>Triazoles--adverse effects<br/>Voriconazole